Rua Bioscience Investor Relations Material
Latest events
AGM 2024
Rua Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Rua Bioscience Limited
Access all reports
Rua Bioscience Limited is a pharmaceutical company focused on the cultivation, research, and production of medicinal cannabis products. The company operates in New Zealand, with a focus on developing cannabinoid-based therapies aimed at improving patient health and well-being. Rua Bioscience emphasizes sustainable cultivation practices and conducts research to support the development of safe and effective cannabis-based medicines. The company is headquartered in Gisborne, New Zealand, and its shares are listed on the NZX.
Key slides for Rua Bioscience Limited
AGM 2024
Rua Bioscience Limited
AGM 2024
Rua Bioscience Limited
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
RUA
Country
🇳🇿 New Zealand